News 2024-08-27
Connect with Porton at CPhI Europe 2024 @ Booth 5C17
CPhI Europe (October 8-10) in Milan, Italy, stands as a worldwide event in the pharmaceutical industry, bringing together key players, thought leaders, and businesses from across the globe. At this year's exhibition, Porton will showcase its end-to-end global CDMO service capabilities across both drug substance and drug product development and manufacturing and the differentiated advantages it offers to customers. From new drug development and process optimization to commercial manufacturing, Porton is dedicated to addressing customer needs and delivering efficient CDMO solutions at the highest quality and service levels. Our expertise spans from small molecules (DS-DP) to Tides, Biologics, and Conjugates.
With more than 62,000 professionals and 2,400 exhibitors hailing from over 166 countries, CPhI Europe is celebrated as one of the world's largest pharmaceutical trade show. This event serves as an unparalleled platform for powerful networking, fostering collaborations, and driving forward the pharmaceutical sector's growth and innovation.
For onsite meeting appointments, please contact: business@portonpharma.com.
Others
More
News 2025-10-20
Porton Warmly Congratulates Partner XZenith on Its Listing on the Main Board of the Hong Kong Stock Exchange
Porton congratulates XZenith on its HK listing, highlighting our CDMO partnership for innovative drug development and commercialization.
News 2025-10-17
Porton Unveils Porton Up 3.0 Project and Launches Quality Month Initiative, Driving Enterprise-Wide Transformation
Porton launches Porton Up 3.0 initiative at Changshou site, driving comprehensive GMP compliance, quality management, and operational excellence upgrades for CDMO partners.